Which drug keeps the nose Blood-Free during surgery? a Head-to-Head trial
NCT ID NCT07660562
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial compares two medications—remifentanil and nicardipine—given during nasal surgery to lower blood pressure and reduce bleeding. Both are already used in practice, but it is unclear which provides a better surgical view and fewer side effects. The study includes adults undergoing elective nasal surgery and measures surgical field quality, blood loss, and recovery time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
remifentanil and nicardipine
What this could lead to
If one drug works better, it could become the preferred method for controlling bleeding during nasal surgeries, leading to safer procedures and better outcomes.
What could go wrong
This is a small, early-stage trial with only 44 participants, so results may not apply to all patients. Both drugs have known side effects like low blood pressure or slow heart rate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASAL SURGERY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••